期刊文献+

泽漆化痰方治疗慢阻肺痰浊阻肺证及对气道黏液高分泌的影响 被引量:15

Effect of Zeqi Huatan Fang on Syndrome of Phlegm-turbidity in COPD and Influence on Airway Mucus Hypersecretion
下载PDF
导出
摘要 目的观察泽漆化痰方治疗慢性阻塞性肺疾病(COPD)肺痰浊阻肺证的临床疗效及对气道黏液高分泌的影响。方法将177例COPD痰浊阻肺证患者随机分为治疗组95例,对照组82例,对照组给予西医基础治疗+沐舒坦片,治疗组给予西医基础治疗+泽漆化痰方药物治疗,两组疗程均为14 d。结果治疗组单项症状咳嗽、咯痰、哮鸣疗效明显优于对照组(P<0.05),喘息症状两组总有效率比较无统计学差异(P>0.05);两组总体疗效及中医证候总积分比较,治疗组均优于对照组(P<0.01);两组对于痰色、质、量的影响,治疗组均优于对照组(P<0.05)。结论泽漆化痰方对COPD痰浊阻肺证患者有较好的治疗作用,且对气道黏液分泌(痰色、质、量)有一定的影响,安全性好。 Objective: To evaluate the effect of Zeqi Huatan Fang on syndrome of phlegm-turbidity in COPD and the influence on airway mucus hypersecretion.Methods: 177 COPD(syndrome of phlegm-turbidity) patients were randomly divided into two groups.The control group was given Ambroxol tablets.The treatment group was given Zeqi Huatan Fang.Both groups were treated for 2 weeks and followed up every week.Results: There was a significant difference between two groups on cough,expectoration and asthma symptoms(P〈0.05).There was no significant difference between two groups on wheezing symptom(P〉0.05).In these indicators,including the phlegm cotor,quality,quantity,general symptom efficacy and the total scores of TCM syndrome,the treatment group was superior to the control group(P〈0.05 or P〈0.01).Conclusion: It is effective and safety of Zeqi Huatan Fang in COPD with syndrome of phlegm-turbidity.It may have influence on airway mucus hypersecretion.
出处 《中国中医急症》 2015年第3期415-417,共3页 Journal of Emergency in Traditional Chinese Medicine
基金 上海市卫生和计划生育委员会中医药科研基金课题(2010L019A)
关键词 COPD 痰浊阻肺证 泽漆化痰方 气道黏液高分泌 COPD Syndrome of phlegm-turbidity Zeqi Huatan Fang Airway mucus hypersecretion
  • 相关文献

参考文献5

二级参考文献25

  • 1有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:279
  • 2王可,冯玉麟,文富强,陈雪融,欧雪梅,徐丹,邓治平,杨劼.慢性阻塞性肺疾病患者气道上皮水通道5的表达与黏液高分泌[J].中国呼吸与危重监护杂志,2006,5(5):357-361. 被引量:11
  • 3李文,毛兵.COPD气道阻塞与黏液高分泌及其中医治疗临床研究现状[J].现代临床医学,2006,32(6):463-465. 被引量:4
  • 4Cerveri I,Brusasco V.Revisited role for mucus hypersecretion in the pathogenesis of COPD.Eur Respir Rev,2010,19:109-112.
  • 5de Marco R,Accordini S,Cerveri I,et al.Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm.Am J Respir Crit Care Med,2007,175:32-39.
  • 6Hogg JC,Chu F,Utokaparch S,et al.The nature of small-airway obstruction in chronic obstructive pulmonary disease.N Engl J Med,2004,350:2645-2653.
  • 7Burgel PR,Nesme-Meyer P,Chanez P,et al.Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects.Chest,2009,135:975-982.
  • 8Hogg JC,Chu FS,Tan WC,et al.Survival after lung volume reduction in chronic obstructive pulmonary disease:insights from small airways pathology.Am J Respir Crit Care Med,2007,176:454-459.
  • 9Burgel PR,Martin C.Mucus hypersecretion in COPD:should we only rely on symptoms? Eur Respir Rev,2010,19:116:94-96.
  • 10Gerrits CM,Herings RM,Leufkens HG,et al.N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease.Eur Respir J,2003,21:795-798.

共引文献9230

同被引文献191

引证文献15

二级引证文献100

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部